Cargando…

Lung cancer treatment in the era of immunotherapy

Detalles Bibliográficos
Autores principales:	Xu, Yang, Chen, Liang-An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575177/ https://www.ncbi.nlm.nih.gov/pubmed/32969863 http://dx.doi.org/10.1097/CM9.0000000000001116

Ejemplares similares

Aspirin in the era of immunotherapy
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Stereotactic body radiation therapy for pancreatic cancer: a potential ally in the era of immunotherapy?
por: Park, Jin-hong
Publicado: (2022)

Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
por: Pabst, Lucile, et al.
Publicado: (2023)

Advancing to the era of cancer immunotherapy
por: Wang, Yun, et al.
Publicado: (2021)

Lung Cancer Risk and Delivering on the Promise of the Genomic Era
por: Arenberg, Douglas
Publicado: (2023)

Cytokine treatment in cancer immunotherapy
por: Ardolino, Michele, et al.
Publicado: (2015)

Induction treatment in operable non-small cell lung cancer: the immune oncology era unfolds
por: Walker, Paul R.
Publicado: (2023)

Small Cell Lung Cancer: A New Era Is Beginning?
por: Morabito, Alessandro, et al.
Publicado: (2021)

Novel Cancer Immunotherapies and Antitumor Immunity
por: Zhao, Lei, et al.
Publicado: (2019)

Gastroenterological Cancer and Immunotherapy
por: Wang, Xiaoping, et al.
Publicado: (2018)

The baby lung and the COVID-19 era
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine
por: Parums, Dinah V.
Publicado: (2021)

Cancer immunotherapy
por: Yan, Li, et al.
Publicado: (2014)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era
por: Chiappetta, Marco, et al.
Publicado: (2023)

What is the role of consolidative thoracic radiotherapy in the era of chemo-immunotherapy for extensive stage small cell lung cancer?
por: Higgins, Kristin A., et al.
Publicado: (2020)

Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy
por: Yang, Zhang-Ru, et al.
Publicado: (2020)

Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
por: Cao, Christopher, et al.
Publicado: (2020)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
por: Li, Huanhuan, et al.
Publicado: (2023)

Developing immunotherapy strategies in the treatment of prostate cancer
por: Gulley, James L., et al.
Publicado: (2016)

Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
por: Singh, Jagmohan, et al.
Publicado: (2021)

Immunotherapy in non‐small cell lung cancer: The past, the present, and the future
por: Lu, Meng, et al.
Publicado: (2019)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?
por: Deboever, Nathaniel, et al.
Publicado: (2022)

Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era
por: Janopaul-Naylor, James R., et al.
Publicado: (2023)

The gut microbiome and its interaction with health, disease, treatment response and toxicity in patients advanced cancer: focus on lung cancer and immunotherapy
por: Tinsley, Nadina, et al.
Publicado: (2020)

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
por: Zhang, Zengfu, et al.
Publicado: (2023)

The Endoscopic Cryotherapy of Lung and Bronchial Tumors: A Systematic Review -Can We Expect a New Era of Cryotherapy in Lung Cancer?
por: Lee, Jinwoo, et al.
Publicado: (2011)

Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it
por: Trestini, I., et al.
Publicado: (2021)

Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
por: Faltermeier, Claire M., et al.
Publicado: (2021)

Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial
por: Facchinetti, Francesco, et al.
Publicado: (2021)

New challenges for lung transplantation in the era of COVID-19
por: Fernandes, Lucas Matos, et al.
Publicado: (2022)

The New Era of Immunotherapy in Gastric Cancer
por: Takei, Shogo, et al.
Publicado: (2022)

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
por: Xia, Wu-Yan, et al.
Publicado: (2020)

Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy
por: Zhou, Maggie Y., et al.
Publicado: (2023)

Cancer Immunotherapy: Theory and Application
por: Chen, Guobing, et al.
Publicado: (2018)

Brain metastases: lessons and challenges in the targeted therapy and immunotherapy era
por: Lau, Peter Kar Han
Publicado: (2020)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Target volume delineation and margins in the management of lung cancers in the era of image guided radiation therapy
por: Lin, Robert
Publicado: (2014)

Cholangiocarcinoma in the Era of Immunotherapy
por: Manthopoulou, Eleni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qn32vnjj7jjotsl7difh2usspb